Please assess the completion status of the following clinical trial:

Trial Title: A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupus

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Willing and able to give written informed consent~2. Between the ages of 18 and 65 years (inclusive)~3. Fulfilled at least 4 ACR classification criteria~4. SLE patients with moderate, active disease~5. Subjects on stable dose of SLE medications for at least 4 weeks before randomization.~6. Women of child-bearing potential must practice a medically acceptable method of contraception..~7. Must understand the requirements of the study and agree to comply with the study protocol.~Exclusion Criteria:~1. Any condition which the investigator feels may interfere with participation in the study.~2. Subjects having a history of chronic infection~3. Subjects with a history of immunodeficiency syndrome or malignancy,~4. Subjects who received any investigational medication (including DHEA) within 3 months prior to randomization,~5. Subjects treated with any cytotoxic agents in the 3 months prior to randomization.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).